3

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: May 30, 2023
Period of Report: May 23, 2023
Accession Number: 0001096906-23-001204

View Document ↗ View on SEC.gov ↗